www.icotherapeutics.com
Click here to view a searchable, detailed profile of this and the many other life sciences organizations across the province on the LifeSciences BC directory powered by flintbox.
For a national directory of life sciences organizations, click here
Address:
760 - 777 Hornby Street
Vancouver, BC V6Z 1S4
Canada
Tel: 604-602-9414
Fax: 604-602-9699
Member Sector: Biopharmaceuticals
iCo Therapeutics Inc. is a Vancouver-based reprofiling company focused on redosing or reformulating drugs with clinical history for new or expanded indications. iCo has exclusive worldwide rights to three products, iCo-007, in Phase I for the treatment of Diabetic Macular Edema, iCo-008, a product with Phase II clinical history to be developed for severe ocular allergies, and iCo-009, an oral reformulation of Amphotericin B for sight and life threatening diseases. iCo-009 also represents a new drug delivery technology with the potential to reprofile other IV administered drugs to the oral route of administration. iCo Therapeutics trades on the TSX-Venture exchange under the symbol “ICO”.